Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TURP Combined with Oral Anticholinergics or Botulinum Toxin A for BPH with Overactive Bladder
IRCT20201225049827N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A in benign prostatic hyperplasia (BPH), overactive bladder (OAB) and Micturition disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign prostatic hyperplasia (BPH)overactive bladder (OAB)Micturition disorder
Beyond the preview
Go deeper on IRCT20201225049827N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201225049827N1.